| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 7 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.61M | $81.37M | +7.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | Patel Snehal61 | CEO And CFO | Buy | 2,000 | $5.40 | $10,795.40 | +0.2% | |
| Sep 29, 2020 | McWilliams David | Director | Buy | 2,608 | $5.75 | $14,996.00 | +0.6% | |
| Sep 29, 2020 | Hallock Kenneth | Director | Buy | 8,333 | $4.60 | $38,352.63 | +2.2% | |
| Sep 29, 2020 | Hallock Kenneth | Director | Buy | 74,782 | $5.75 | $429,996.50 | +41.0% | |
| Sep 29, 2020 | Patel Snehal61 | CEO And CFO | Buy | 114,347 | $5.75 | $657,495.25 | +15.3% | |
| Sep 29, 2020 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,739 | $5.75 | $9,999.25 | +2.1% | |
| Sep 29, 2020 | Patel Snehal61 | CEO And CFO | Buy | 16,667 | $4.60 | $76,709.87 | +1.4% |